1
|
Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma.
|
Eur J Surg Oncol
|
2012
|
2.96
|
2
|
Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome.
|
Hepatology
|
1996
|
2.47
|
3
|
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.
|
Cancer Treat Rev
|
2010
|
2.09
|
4
|
New therapies for hepatocellular carcinoma.
|
Oncogene
|
2006
|
2.05
|
5
|
Liver transplantation in cirrhotic patients with diabetes mellitus: midterm results, survival, and adverse events.
|
Liver Transpl
|
2001
|
1.44
|
6
|
Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application.
|
Curr Gene Ther
|
2003
|
1.42
|
7
|
Liver transplantation in cirrhotic patients over 60 years of age.
|
Rev Esp Enferm Dig
|
1998
|
1.38
|
8
|
Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma.
|
Liver Transpl
|
2001
|
1.25
|
9
|
Hepatitis B and C viral infections in patients with hepatocellular carcinoma.
|
Hepatology
|
1992
|
1.10
|
10
|
Totally laparoscopic right-lobe hepatectomy for adult living donor liver transplantation: useful strategies to enhance safety.
|
Am J Transplant
|
2013
|
1.07
|
11
|
Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12.
|
Hepatology
|
2001
|
1.04
|
12
|
Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters.
|
Hepatology
|
1995
|
1.03
|
13
|
Genetic heterogeneity in the toxicity to systemic adenoviral gene transfer of interleukin-12.
|
Gene Ther
|
2001
|
0.98
|
14
|
Liver changes in patients with hyperthyroidism.
|
Liver
|
1991
|
0.94
|
15
|
Splenic embolization prior to myelosuppressive treatment in hepatocarcinoma and active chronic hepatitis.
|
Eur J Radiol
|
1992
|
0.93
|
16
|
No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors.
|
Mol Pharm
|
2012
|
0.93
|
17
|
The promise of gene therapy in gastrointestinal and liver diseases.
|
Gut
|
2003
|
0.92
|
18
|
Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas.
|
Gene Ther
|
1999
|
0.92
|
19
|
Ribavirin in desquamative interstitial pneumonia.
|
Chest
|
1988
|
0.92
|
20
|
Plasma levels of substance P in liver cirrhosis: relationship to the activation of vasopressor systems and urinary sodium excretion.
|
Hepatology
|
1995
|
0.90
|
21
|
[Spontaneous tumor regression. Report of 2 cases].
|
Med Clin (Barc)
|
1990
|
0.89
|
22
|
Liver damage using suicide genes. A model for oval cell activation.
|
Am J Pathol
|
2000
|
0.88
|
23
|
Risk factors for recurrence of hepatitis C after liver transplantation.
|
Liver Transpl Surg
|
1998
|
0.87
|
24
|
Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation.
|
Transplant Proc
|
2012
|
0.87
|
25
|
Gene therapy of hepatocellular carcinoma.
|
Dig Dis
|
2001
|
0.85
|
26
|
Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil.
|
Liver Transpl Surg
|
1999
|
0.85
|
27
|
Color Doppler-US guidance in transjugular placement of intrahepatic portosystemic shunts.
|
Radiology
|
1992
|
0.85
|
28
|
Gene transfer and therapy with adenoviral vector in rats with diethylnitrosamine-induced hepatocellular carcinoma.
|
Hum Gene Ther
|
1997
|
0.84
|
29
|
Gene therapy for liver diseases: recent strategies for treatment of viral hepatitis and liver malignancies.
|
Gut
|
2002
|
0.84
|
30
|
Prognostic model for early acute rejection after liver transplantation.
|
Liver Transpl
|
2001
|
0.83
|
31
|
Laparotomic eventration or colonic prolapse after chemotherapy-induced emesis.
|
J Surg Oncol
|
1988
|
0.82
|
32
|
Idiopathic adulthood ductopenia: long-term follow-up after liver transplantation.
|
Dig Dis Sci
|
2001
|
0.82
|
33
|
Aortic valve replacement with bioprostheses in liver transplant recipients.
|
J Heart Valve Dis
|
2000
|
0.79
|
34
|
Partial splenic embolization in the treatment of thrombocytopenia after liver transplantation.
|
Transplantation
|
1997
|
0.78
|
35
|
Failure of high-dose tocopherol to prevent alopecia induced by doxorubicin.
|
N Engl J Med
|
1986
|
0.78
|
36
|
Conversion from calcineurin inhibitors to mycophenolate mofetil in liver transplant recipients with diabetes mellitus.
|
Transplant Proc
|
2003
|
0.77
|
37
|
Hyperhomocysteinemia in liver transplant recipients: prevalence and multivariate analysis of predisposing factors.
|
Liver Transpl
|
2000
|
0.77
|
38
|
Antiemetic combination for PAC (cisplatin-adriamycin-cyclophosphamide) chemotherapy-induced emesis in ovarian cancer.
|
Eur J Gynaecol Oncol
|
1987
|
0.77
|
39
|
Increased concentrations of tumor necrosis factor and interleukin-6 contribute to the hemostatic abnormalities in advanced liver disease.
|
Haemostasis
|
1996
|
0.76
|
40
|
Whole body 18fluoro-L-dopa PET-CT: a useful tool for location and surgical guidance in primary carcinoid tumours.
|
Eur J Nucl Med Mol Imaging
|
2008
|
0.75
|
41
|
Downstaging to liver resection by radioembolization: a difficult to reach strategy? Author reply.
|
Eur J Surg Oncol
|
2013
|
0.75
|
42
|
[Fatal pulmonary embolism after embolization of a hepatocellular carcinoma using microspheres].
|
Radiologia
|
2008
|
0.75
|
43
|
Renal biopsy with forceps through the femoral vein.
|
J Vasc Interv Radiol
|
1995
|
0.75
|
44
|
Felty's syndrome: response to cyclosporin A with disappearance of neutrophil autoantibodies.
|
Arthritis Rheum
|
1991
|
0.75
|
45
|
[Antiemetic inefficacy of high intravenous doses of metoclopramide by short-term infusion in vomiting induced by antineoplastic chemotherapy].
|
Med Clin (Barc)
|
1986
|
0.75
|
46
|
Effectiveness of lamivudine in treatment of acute recurrent hepatitis B after liver transplantation.
|
Dig Dis Sci
|
1998
|
0.75
|
47
|
Subsequent nonmelanoma skin cancer after liver transplantation.
|
Transplant Proc
|
2012
|
0.75
|
48
|
Increased liver stiffness values in patients with heart failure.
|
Acta Gastroenterol Belg
|
2013
|
0.75
|
49
|
Gene therapy of primary and metastatic liver tumors.
|
Med Sci Monit
|
2001
|
0.75
|
50
|
[Treatment of chronic hepatitis B virus infection].
|
An Sist Sanit Navar
|
2004
|
0.75
|
51
|
[Gene therapy: what is it and what is its use?].
|
An Sist Sanit Navar
|
2005
|
0.75
|
52
|
Transvenous liver biopsy in patients with cirrhosis with use of the femoral venous approach and a flexible forceps.
|
J Vasc Interv Radiol
|
1994
|
0.75
|
53
|
Effectiveness of aprotinin in orthotopic liver transplantation.
|
Semin Thromb Hemost
|
1993
|
0.75
|
54
|
[Severe hepatotoxicity caused by amiodarone: description of a case].
|
Rev Med Univ Navarra
|
2001
|
0.75
|
55
|
Results of two controlled studies on antiemetic combination against vomiting induced by 5-fluorouracil.
|
Tumori
|
1987
|
0.75
|